GlobeNewswire

Le KFSH de Riyad figure parmi les 5 % des meilleurs établissements de santé au monde pour le tourisme médical selon le classement 2027 de Newsweek
06/11/2026
RIYAD, Arabie saoudite, 06 nov. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) de Riyad se classe parmi les 5 % des meilleurs établissements de santé répertoriés dans l’édition [...]
Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
06/11/2026
BASEL, Switzerland, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ultragenyx (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, [...]
Nxera Pharma Announces Vamorolone Selected for South Korea’s Accelerated Reimbursement Pilot Program for Rare Disease Treatments
06/11/2026
Vamorolone is one of five treatments selected for the rare disease reimbursement pilot program. The program aims to shorten the National Health Insurance listing process to within 100 days. Together with GIFT priority [...]
Nature Medicine Publication Reveals How Human Movement Predicts Hidden Biosignals Spanning 18 Body Systems, from Heart and Liver Function to Metabolic and Mental Health
06/11/2026
Peer-reviewed study of 3,328 adults links subtle movement patterns to 1,887 health measures and finds independent predictive information across nearly every major body system evaluated Newton Tech is translating this [...]
Major shareholder announcement - BlackRock, Inc.
06/11/2026
ANNOUNCEMENT NO. 326 6 November 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec A/S that, on 2 November 2026, BlackRock, Inc. reduced [...]
Groundbreaking therapy for advanced heart failure: Repairon’s Scientific Co-Founder, Prof. Wolfram-Hubertus Zimmermann, Receives the 2026 “Galenus-von-Pergamon” Award for Outstanding Basic Pharmacological Research
06/11/2026
GÖTTINGEN, Germany and PROVIDENCE, R.I., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Professor Zimmermann and his research team are recognized for the development of iPSC-derived engineered heart muscle, Repairon’s BioVAT lead [...]
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
06/11/2026
Approval extends existing U.K. indication for Joenja to eligible children aged 4 to 11 who weigh at least 27 kg Joenja is expected to become available to patients covered by the expanded indication in February 2027 [...]
Avance Clinical Brings 30 Years of Early-Phase and Therapeutic Leadership to European Biotechs at BIO-Europe 2026
06/11/2026
Australian fast-start pathway, four Centers of Excellence and a GlobalReady model that takes programs from first-in-human to global Phase II without changing CROs ADELAIDE, Australia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- [...]
Global Health Congress 2026 Draws 625+ Leaders From 25 Countries to New York, Names Venture Forum Winners and Announces National and International Expansion
06/11/2026
Second annual Congress at the Yale Club of New York City unites health system CEOs, physicians, technologists and investors; Healthcare Shark Tank led by Robert Herjavec fields 360+ startup applications from 35+ [...]
Orchestra BioMed Announces Pricing of Public Offering
06/11/2026
NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients [...]
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2026
05/11/2026
SAN RAMON, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report fourth quarter and full year 2026 financial results on Thursday [...]
Ossium Health to Present One-Year Outcomes in Highly Mismatched Organ Donor Bone Marrow Transplants at ASH 2026
06/11/2026
SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ossium Health, a bioengineering company that built the world's first bank of organ donor-derived bone marrow, today announced that four abstracts have been selected for [...]
MediPharm Labs Achieves Critical European Regulatory Milestone Supporting Commercialization of Proprietary Metered-Dose Cannabis Inhaler Platform
06/11/2026
Positive Article 117 Notified Body Opinion satisfies a key EU regulatory requirement for an advanced cannabis drug-device combination product and supports planned commercialization in the UK and Europe TORONTO, Nov. 05 [...]
South San Jose Family Dentistry Launches Under New Owner Dr. Dillon Chang, Continuing 40 Years as a Family Dentist in San Jose
06/11/2026
Following Dr. Les M. Wong's retirement after 40 years at the Blossom Hill Road location, the practice formerly known as San Jose Smile Design has new ownership and a new name and brand, with the same location, phone [...]
Equillium to Participate in Upcoming Investor Conferences
05/11/2026
LA JOLLA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat serious autoimmune and inflammatory disorders, today announced that [...]
Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth
05/11/2026
Gross margin reaches 78%; cash used in operating activities declines 56% sequentially Profound expects full-year 2026 revenue to be at least $25.0 million; minimum gross margin projection for the year remains at 70% or [...]
RenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million
05/11/2026
Active Commercial Cancer Center Customers Increased to 26 and Total Commercial Funnel Grows to More Than 65 Centers Maintains 2026 Annual Revenue Guidance of $3.75M to $4.25M First Physician-Driven Expansion Using TAMP [...]
Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/11/2026
NEEDHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
Sight Sciences to Present at Two Upcoming Investor Conferences
05/11/2026
MENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum